最新的帖子

四月 19, 2021

NovaPure® Components Answer Your Concerns over Particulates in Biologics

An enormous growth trend is being observed in the market for biologic drugs; they are being employed ever more frequently as treatments for chronic issues such as cancer and autoimmune diseases. This growth is reflected by the number of companies involved (established and emerging), and in the capital investment for manufacturing facilities for both biologics and biosimilars. Companies must apply a holistic approach to bringing a biologic drug to market. 
Qian Liu

Nancy Liu

Sr. Specialist, TCS, China

以前的博客

十二月 28, 2020

Particles in Injectable Drugs

Lynn Yao

Lynn Yao

Manager, Scientific Affairs, CN

Load more